16:23 EDT BioAge Labs (BIOA) files automatic mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOA:
- BioAge Highlights BGE-102 Progress and Financial Strength
- BIOA Earnings this Week: How Will it Perform?
- BioAge Labs price target raised to $52 from $15 at Citi
- BioAge Labs: Differentiated NLRP3 Inhibitor BGE-102 Positions Company for Best-in-Class Cardiometabolic Upside and Strategic M&A Appeal
- BioAge Labs initiated with an Outperform at Oppenheimer